- Home
- MPU vs VTVT Comparison
MPU vs VTVT Comparison
Compare MPU & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- VTVT
- Stock Information
- Founded
- MPU 1989
- VTVT 2015
- Country
- MPU Singapore
- VTVT United States
- Employees
- MPU N/A
- VTVT N/A
- Industry
- MPU Transportation Services
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- MPU Consumer Discretionary
- VTVT Health Care
- Exchange
- MPU Nasdaq
- VTVT Nasdaq
- Market Cap
- MPU 43.5M
- VTVT 38.8M
- IPO Year
- MPU 1998
- VTVT 2015
- Fundamental
- Price
- MPU $0.90
- VTVT $20.20
- Analyst Decision
- MPU
- VTVT Strong Buy
- Analyst Count
- MPU 0
- VTVT 1
- Target Price
- MPU N/A
- VTVT $35.00
- AVG Volume (30 Days)
- MPU 113.4K
- VTVT 9.0K
- Earning Date
- MPU 03-17-2025
- VTVT 03-12-2025
- Dividend Yield
- MPU N/A
- VTVT N/A
- EPS Growth
- MPU N/A
- VTVT N/A
- EPS
- MPU N/A
- VTVT N/A
- Revenue
- MPU $26,001,000.00
- VTVT $1,000,000.00
- Revenue This Year
- MPU N/A
- VTVT N/A
- Revenue Next Year
- MPU N/A
- VTVT N/A
- P/E Ratio
- MPU N/A
- VTVT N/A
- Revenue Growth
- MPU 1444400.00
- VTVT 11011.11
- 52 Week Low
- MPU $0.77
- VTVT $8.10
- 52 Week High
- MPU $3.33
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- MPU 37.01
- VTVT 63.15
- Support Level
- MPU $0.88
- VTVT $19.02
- Resistance Level
- MPU $1.10
- VTVT $20.89
- Average True Range (ATR)
- MPU 0.14
- VTVT 1.15
- MACD
- MPU 0.01
- VTVT 0.30
- Stochastic Oscillator
- MPU 15.38
- VTVT 68.18
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.